Author

Dagim Shiferaw Tadele

Oslo University HospitalORCID 0000-0001-8319-678XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrea LenartovaiD· 1 shared Andrea M. Brodersen· 1 shared Andriy MarusykiD· 1 shared Aram Nikolai AnderseniD· 1 shared Arda DurmaziD· 1 shared Davis T. WeaveriD· 1 shared Endalkachew Ashenafi Alemu· 1 shared Jacob G. ScottiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Andrea LenartovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 2, 2024

Cell-Cell Fusion in NSCLC Promotes Evolution of Therapeutic Resistance

Paulameena V. Shultes, Dagim Shiferaw Tadele, Arda Durmaz…·Jacob G. Scott

This study shows that cell-cell fusion in NSCLC leads to increased chemoresistance and tumor aggressiveness by creating hybrid cells with enhanced fitness and genomic heterogeneity.

DOI 10.1101/2024.12.02.626399

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintOct 11, 2022

Clinical Forecasting using Ex Vivo Drug Sensitivity Profiling of Acute Myeloid Leukemia

Aram Nikolai Andersen, Andrea M. Brodersen, Pilar Ayuda Durán…·Jorrit M. Enserink

This study evaluates ex vivo drug sensitivity profiling in AML patients to predict survival and chemotherapy response, showing its robustness in mapping treatment response signatures.

1 citation

humanstatistical model

𝕏 PostBluesky